JOAN HARTER: Open Payments
NPI 1114971322 · OROVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$748 in 42 payments from 14 companies in 2025. Trend: 2023 $309 · 2024 $619 · 2025 $748
Food & beverage: $748
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $279 |
| PFIZER INC. | 4 | $88 |
| Dexcom, Inc. | 2 | $63 |
| Indivior Inc. | 3 | $50 |
| Novo Nordisk Inc | 2 | $46 |
| Viatris Specialty LLC | 2 | $39 |
| Phathom Pharmaceuticals, Inc. | 2 | $32 |
| Amgen Inc. | 1 | $27 |
| KYOWA KIRIN, INC. | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
Products named: UBRELVY, MAVYRET, NURTEC ODT, Dexcom G6 Transmitter, SUBLOCADE, QULIPTA, YUPELRI, VOQUEZNA.
Industry payments across CA — which companies pay providers there.
